Skip to main content

Fermentalg S.A. (FALG.PA)

Euronext Healthcare BiotechnologyView data quality →
36.4Poor

ValueMarkers Composite Index

Top 3%#43,553 of 44,707

DCF data not available

Piotroski
2/9
Weak
Beneish
-1.17
High Risk
Altman
0.11
Distress
DCF Value
-
N/A
ROIC
-34.9%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Fermentalg S.A. (FALG.PA) — VMCI valuation read

The headline on Fermentalg S.A. (FALG.PA) is a 36/100 VMCI score, set against a Healthcare sector median of 50. That 14-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

FALG.PA insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** FALG.PA trades at 25.0x earnings, 39% above the Healthcare median of 18.0x sets the value side. ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 0.3x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on FALG.PA.

FALG.PA rose 3.2% over the trailing 7 days, with a -12.8% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in FALG.PA’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.